Skip to main content
Senate Bill 0211

Senate Bill 0211

ARCHIVE (2012)

Latest Information


Generic drug bidding program. Requires the drug utilization review board (board) to establish a competitive bidding program for generically equivalent drug product manufacturers (manufacturer) of drugs in therapeutic drug classifications with at least three manufactured generically equivalent drug products. Requires a manufacturer that participates in Medicaid or the children's health insurance program (CHIP) to participate in the competitive bidding program. Requires the board to establish a Medicaid preferred generic drug list (list) based on the successful bids and requires prior authorization on the Medicaid program and CHIP for a generically equivalent drug product that is not included on the list. Requires a manufacturer of a generically equivalent drug product that is included on the list to offer state supplement rebates. Requires the office of Medicaid policy and planning to request bids under the competitive bidding program at least one time every five years.
    Current Status:
    In Committee - first House
    Latest Printing (PDF)